AI system for exercise rehab in breast cancer survivors
Part of Cancer, Skin clinical trials.
This study tests a new AI-based skeleton recognition system to guide rehabilitation exercises for breast cancer survivors. It may help reduce pain and improve mobility for those taking aromatase inhibitors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with hormone receptor-positive breast cancer (stage I, II, or III).
- You are currently taking an aromatase inhibitor (like anastrozole, letrozole, or exemestane) for breast cancer.
- You are a woman who has gone through menopause (natural or from surgery).
- You have bone or joint pain (at least a 3 on a 0–10 pain scale) or certain risk factors for bone problems (like abnormal bone markers or low vitamin D).
- You are not currently in another exercise or physical therapy program that could interfere with this study.
- You do not have: recurrence or spread of breast cancer, other cancers, rheumatoid arthritis, severe bone/joint disease, or a T-score below -2.5 on a bone density test.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses an artificial intelligence app to create a personal exercise plan for you after your main breast cancer treatment. The goal is to help you recover and improve your health.
This trial tests a new program to help breast cancer survivors become more active. The program is delivered remotely using a smartphone app, and it adjusts based on your progress. It may be a good fit if you finished treatment less than 5 years ago and are not very active yet.
This study tests whether a personalized 14-week exercise program, guided by a physiotherapist, can help people with breast cancer during their chemotherapy or hormone therapy before surgery. It also looks at certain biological markers in blood or tissue samples to learn more about how the body responds to treatment and exercise.
This trial tests whether starting a gentle exercise program early can help prevent or reduce joint and muscle pain caused by aromatase inhibitors (a common breast cancer medicine). It is for women with hormone-sensitive breast cancer who are not yet experiencing severe pain from their treatment.
This trial tests a non-invasive, AI-based monitoring program for people with solid tumors. It aims to help track how you’re doing during or after curative-intent treatment, using information collected without extra procedures.
This study tests a new approach to help breast cancer survivors become more physically active. You will be asked to participate in a program that uses a smartphone app and wear a monitor to track activity.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.